Elekta AB (publ)

Research Elekta AB (publ) (EKTA-B) on Bullrun: market cap SEK 21.45B, dividend yield 4.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 21.45B; dividend yield is 4.4%.

Peer valuation comparison

Latest dividend yield is 4.41% versus a Healthcare sector median of 2.11% (109.0% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 17.57BSEK 292.00MSEK 1.97B37.9%0.76SEK 2.58BSEK 7.60BSEK 8.45B
FY2023SEK 18.12BSEK 1.30BSEK 2.21B37.4%3.41SEK 2.78BSEK 5.93BSEK 10.77B
FY2022SEK 16.87BSEK 944.00MSEK 1.76B37.6%2.47SEK 3.28BSEK 5.72BSEK 9.73B
FY2021SEK 14.55BSEK 1.16BSEK 1.67B37.4%3.02SEK 3.08BSEK 4.61BSEK 8.92B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24SEK 21.45Bn/a4.3%2.4

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.4 SEK, yield 4.4%.

YearDividends/share
FY20232.4 SEK
FY20222.3 SEK
FY20212 SEK

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Elekta AB (publ)'s market cap?

Elekta AB (publ)'s market capitalization is SEK 21.45B.

Does Elekta AB (publ) pay a dividend?

Elekta AB (publ) has a dividend yield of 4.4%.

What does Elekta AB (publ) do?

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear machines and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo, a CT-Linac solution; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions.